Dutch researchers found patient-centered diabetes care was associated with an A1C decline of 0.83% at one year and an incremental cost-effectiveness ratio of $261 per quality-adjusted life year in patients whose baseline A1C was greater than 8.5%. However, such an approach to care did not provide similar benefits in patients with baseline A1C below 7%, researchers reported in Diabetes Care.

Related Summaries